332 related articles for article (PubMed ID: 14769622)
1. Epoetin alfa. Clinical evolution of a pleiotropic cytokine.
Henry DH; Bowers P; Romano MT; Provenzano R
Arch Intern Med; 2004 Feb; 164(3):262-76. PubMed ID: 14769622
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin, the biology of erythropoiesis and epoetin alfa. An overview.
Bieber E
J Reprod Med; 2001 May; 46(5 Suppl):521-30. PubMed ID: 11396386
[TBL] [Abstract][Full Text] [Related]
3. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
Voravud N; Sriuranpong V; Suwanrusme H
J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
[TBL] [Abstract][Full Text] [Related]
4. Experience with epoetin alfa and acquired immunodeficiency syndrome anemia.
Henry DH
Semin Oncol; 1998 Jun; 25(3 Suppl 7):64-8. PubMed ID: 9671334
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
[TBL] [Abstract][Full Text] [Related]
6. Treatment of cancer-related anemia with epoetin alfa: a review.
Ferrario E; Ferrari L; Bidoli P; De Candis D; Del Vecchio M; De Dosso S; Buzzoni R; Bajetta E
Cancer Treat Rev; 2004 Oct; 30(6):563-75. PubMed ID: 15325036
[TBL] [Abstract][Full Text] [Related]
7. Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa.
Agnihotri P; Telfer M; Butt Z; Jella A; Cella D; Kozma CM; Ahuja M; Riaz S; Akamah J
J Am Geriatr Soc; 2007 Oct; 55(10):1557-65. PubMed ID: 17697104
[TBL] [Abstract][Full Text] [Related]
8. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
[TBL] [Abstract][Full Text] [Related]
9. Epoetin alfa's effect on left ventricular hypertrophy and subsequent mortality.
Jones M; Schenkel B; Just J
Int J Cardiol; 2005 Apr; 100(2):253-65. PubMed ID: 15823633
[TBL] [Abstract][Full Text] [Related]
10. Central nervous system frontiers for the use of erythropoietin.
Olsen NV
Clin Infect Dis; 2003; 37 Suppl 4():S323-30. PubMed ID: 14582001
[TBL] [Abstract][Full Text] [Related]
11. Anemia and response to epoetin alfa: the cause of anemia matters!
Dharmarajan TS
J Am Geriatr Soc; 2008 Aug; 56(8):1574-5. PubMed ID: 18808607
[No Abstract] [Full Text] [Related]
12. Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C.
Stravitz RT; Chung H; Sterling RK; Luketic VA; Sanyal AJ; Price AS; Purrington A; Shiffman ML
Am J Gastroenterol; 2005 Jun; 100(6):1415-9. PubMed ID: 15929778
[TBL] [Abstract][Full Text] [Related]
13. Implications of anemia in human immunodeficiency virus, cancer, and hepatitis C virus.
Mildvan D
Clin Infect Dis; 2003; 37 Suppl 4():S293-6. PubMed ID: 14581997
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients.
Rossert J; Gassmann-Mayer C; Frei D; McClellan W
Nephrol Dial Transplant; 2007 Mar; 22(3):794-800. PubMed ID: 17210593
[TBL] [Abstract][Full Text] [Related]
15. Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy.
Pockros PJ; Shiffman ML; Schiff ER; Sulkowski MS; Younossi Z; Dieterich DT; Wright TL; Mody SH; Tang KL; Goon BL; Bowers PJ; Leitz G; Afdhal NH;
Hepatology; 2004 Dec; 40(6):1450-8. PubMed ID: 15565613
[TBL] [Abstract][Full Text] [Related]
16. Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa.
Lefebvre P; Vekeman F; Sarokhan B; Enny C; Provenzano R; Cremieux PY
Curr Med Res Opin; 2006 Oct; 22(10):1929-37. PubMed ID: 17022852
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of epoetin supplemented with oral iron in patients with solid malignancies and chronic anemia not receiving anticancer treatment.
Mystakidou K; Kalaidopoulou O; Katsouda E; Parpa E; Kouskouni E; Chondros C; Tsiatas ML; Vlahos L
Anticancer Res; 2005; 25(5):3495-500. PubMed ID: 16101168
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of anemia in clinic patients with heart failure and cost analysis of epoetin treatment.
Choy CK; Spencer AP; Nappi JM
Pharmacotherapy; 2007 May; 27(5):707-14. PubMed ID: 17461706
[TBL] [Abstract][Full Text] [Related]
19. 2009: a requiem for rHuEPOs--but should we nail down the coffin in 2010?
Goldsmith D
Clin J Am Soc Nephrol; 2010 May; 5(5):929-35. PubMed ID: 20413441
[TBL] [Abstract][Full Text] [Related]
20. The impact of anemia on quality of life in human immunodeficiency virus-infected patients.
Volberding P
J Infect Dis; 2002 May; 185 Suppl 2():S110-4. PubMed ID: 12001031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]